Chrontech Pharma AB
Records under this name other than patents Chrontech Pharma AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,303,956 | Glycosylated Specificity Exchangers Formerly held Lapsed on the fee record Ended Nov 6, 2020 · Medium confidence | Lapsed on the fee record | Ended Nov 6, 2020 | Medium confidence |
| US 6,680,059 | Vaccines Containing Ribavirin and Methods of Use Thereof Formerly held Term ended Ended no later than Nov 3, 2020 · Low confidence | Term ended | Ended no later than Nov 3, 2020 | Low confidence |
| US 7,439,347 | Hepatitis C Virus Non-Structural NS3/4A Fusion Gene Formerly held Lapsed on the fee record Ended Oct 21, 2020 · Medium confidence | Lapsed on the fee record | Ended Oct 21, 2020 | Medium confidence |
| US 9,457,183 | Injection Needle and Device Formerly held Lapsed on the fee record Ended Oct 4, 2020 · High confidence | Lapsed on the fee record | Ended Oct 4, 2020 | High confidence |
| US 8,258,275 | Immunogen Platform Formerly held Lapsed on the fee record Ended Sep 4, 2020 · High confidence | Lapsed on the fee record | Ended Sep 4, 2020 | High confidence |
| US 8,163,547 | Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene Formerly held Lapsed on the fee record Ended Apr 24, 2020 · Medium confidence | Lapsed on the fee record | Ended Apr 24, 2020 | Medium confidence |
| US 8,163,712 | Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene Formerly held Lapsed on the fee record Ended Apr 24, 2020 · Medium confidence | Lapsed on the fee record | Ended Apr 24, 2020 | Medium confidence |
| US 8,158,602 | Hepatitis C Virus Codon Optimized Non-Structural NS3/4A Fusion Gene Formerly held Lapsed on the fee record Ended Apr 17, 2020 · Medium confidence | Lapsed on the fee record | Ended Apr 17, 2020 | Medium confidence |
| US 6,245,895 | Antigen/antibody specificity exchanger Formerly held Term ended Term ended Mar 21, 2020 · From the USPTO record | Term ended | Term ended Mar 21, 2020 | From the USPTO record |
| US 7,335,359 | Glycosylated Specificity Exchangers Formerly held Lapsed on the fee record Ended Feb 26, 2020 · Medium confidence | Lapsed on the fee record | Ended Feb 26, 2020 | Medium confidence |